204 related articles for article (PubMed ID: 11973644)
1. Differential function of STAT5 isoforms in head and neck cancer growth control.
Leong PL; Xi S; Drenning SD; Dyer KF; Wentzel AL; Lerner EC; Smithgall TE; Grandis JR
Oncogene; 2002 Apr; 21(18):2846-53. PubMed ID: 11973644
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of Stat5b contributes to carcinogenesis in vivo.
Xi S; Zhang Q; Gooding WE; Smithgall TE; Grandis JR
Cancer Res; 2003 Oct; 63(20):6763-71. PubMed ID: 14583472
[TBL] [Abstract][Full Text] [Related]
3. Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.
Song JI; Lango MN; Hwang JD; Drenning SD; Zeng Q; Lamph WW; Grandis JR
Cancer Res; 2001 Aug; 61(15):5919-25. PubMed ID: 11479234
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor--mediated stat3 signaling blocks apoptosis in head and neck cancer.
Rubin Grandis J; Zeng Q; Drenning SD
Laryngoscope; 2000 May; 110(5 Pt 1):868-74. PubMed ID: 10807365
[TBL] [Abstract][Full Text] [Related]
5. STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo.
Kijima T; Niwa H; Steinman RA; Drenning SD; Gooding WE; Wentzel AL; Xi S; Grandis JR
Cell Growth Differ; 2002 Aug; 13(8):355-62. PubMed ID: 12193474
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
Rubin Grandis J; Chakraborty A; Melhem MF; Zeng Q; Tweardy DJ
Oncogene; 1997 Jul; 15(4):409-16. PubMed ID: 9242377
[TBL] [Abstract][Full Text] [Related]
7. STAT signaling in head and neck cancer.
Song JI; Grandis JR
Oncogene; 2000 May; 19(21):2489-95. PubMed ID: 10851047
[TBL] [Abstract][Full Text] [Related]
8. Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
Grandis JR; Chakraborty A; Zeng Q; Melhem MF; Tweardy DJ
J Cell Biochem; 1998 Apr; 69(1):55-62. PubMed ID: 9513046
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA
J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
[TBL] [Abstract][Full Text] [Related]
10. Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells.
Yamashita H; Iwase H; Toyama T; Fujii Y
Oncogene; 2003 Mar; 22(11):1638-52. PubMed ID: 12642867
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor.
Shao H; Cheng HY; Cook RG; Tweardy DJ
Cancer Res; 2003 Jul; 63(14):3923-30. PubMed ID: 12873986
[TBL] [Abstract][Full Text] [Related]
12. Signal transducers and activators of transcription 5B potentiates v-Src-mediated transformation of NIH-3T3 cells.
Kazansky AV; Rosen JM
Cell Growth Differ; 2001 Jan; 12(1):1-7. PubMed ID: 11205741
[TBL] [Abstract][Full Text] [Related]
13. Delineation and mapping of Stat5 isoforms activated by granulocyte colony-stimulating factor in myeloid cells.
Chakraborty A; Dyer KF; Tweardy DJ
Blood Cells Mol Dis; 2000 Aug; 26(4):320-30. PubMed ID: 11042034
[TBL] [Abstract][Full Text] [Related]
14. Constitutively active STAT5A and STAT5B in vitro and in vivo: mutation of STAT5 is not a frequent cause of leukemogenesis.
Yamada K; Ariyoshi K; Onishi M; Miyajima A; Hayakawa F; Towatari M; Saito H; Oka Y; Asano S; Nosaka T; Kitamura T
Int J Hematol; 2000 Jan; 71(1):46-54. PubMed ID: 10729993
[TBL] [Abstract][Full Text] [Related]
15. EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytes.
Guren TK; Ødegård J; Abrahamsen H; Thoresen GH; Susa M; Andersson Y; Østby E; Christoffersen T
J Cell Physiol; 2003 Jul; 196(1):113-23. PubMed ID: 12767047
[TBL] [Abstract][Full Text] [Related]
16. IL-2 and IL-7 induce heterodimerization of STAT5 isoforms in human peripheral blood T lymphoblasts.
Rosenthal LA; Winestock KD; Finbloom DS
Cell Immunol; 1997 Nov; 181(2):172-81. PubMed ID: 9398404
[TBL] [Abstract][Full Text] [Related]
17. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
[TBL] [Abstract][Full Text] [Related]
18. Experimental regulation of STAT gene expression reveals an involvement of STAT5 in interleukin-4-driven cell proliferation.
Friedrich K; Wietek S
Biol Chem; 2001 Feb; 382(2):343-51. PubMed ID: 11308032
[TBL] [Abstract][Full Text] [Related]
19. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
Zhang Q; Thomas SM; Xi S; Smithgall TE; Siegfried JM; Kamens J; Gooding WE; Grandis JR
Cancer Res; 2004 Sep; 64(17):6166-73. PubMed ID: 15342401
[TBL] [Abstract][Full Text] [Related]
20. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.
Grandis JR; Tweardy DJ
Cancer Res; 1993 Aug; 53(15):3579-84. PubMed ID: 8339264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
